1
|
Gulia A, Fried I and Massone C: New
insights in the pathogenesis and genetics of leprosy. F1000 Med
Rep. 2:302010. View
Article : Google Scholar : PubMed/NCBI
|
2
|
World Health Organization. Global leprosy
situation, 2012. Wkly Epidemiol Rec. 87:317–328. 2012.
|
3
|
Lavado-Valenzuela R, José Bravo M,
Junqueira-Kipnis AP, et al: Distribution of the HLA class II
frequency alleles in patients with leprosy from the mid-west of
Brazil. Int J Immunogenet. 38:255–258. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Alvarado-Navarro A, Montoya-Buelna M,
Munoz-Valle JF, Lopez-Roa RI, Guillen-Vargas C and Fafutis-Morris
M: The 3′UTR 1188 A/C polymorphism in the interleukin-12p40 gene
(IL-12B) is associated with lepromatous leprosy in the west of
Mexico. Immunol Lett. 118:148–151. 2008.
|
5
|
Larrea MR, Carreno MC and Fine PE:
Patterns and trends of leprosy in Mexico: 1989–2009. Lepr Rev.
83:184–194. 2012.PubMed/NCBI
|
6
|
Vanderborght PR, Pacheco AG, Moraes ME, et
al: HLA-DRB1*04 and DRB1*10 are associated with resistance and
susceptibility, respectively, in Brazilian and Vietnamese leprosy
patients. Genes Immun. 8:320–324. 2007.
|
7
|
Misch EA, Berrington WR, Vary JC Jr and
Hawn TR: Leprosy and the human genome. Microbiol Mol Biol Rev.
74:589–620. 2010. View Article : Google Scholar
|
8
|
Alter A, Grant A, Abel L, Alcais A and
Schurr E: Leprosy as a genetic disease. Mamm Genome. 22:19–31.
2011. View Article : Google Scholar
|
9
|
Zhang FR, Huang W, Chen SM, et al:
Genomewide association study of leprosy. N Engl J Med.
361:2609–2618. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Miller EN, Jamieson SE, Joberty C, et al:
Genome-wide scans for leprosy and tuberculosis susceptibility genes
in Brazilians. Genes Immun. 5:63–67. 2004. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hsieh NK, Chu CC, Lee NS, Lee HL and Lin
M: Association of HLA-DRB1*0405 with resistance to multibacillary
leprosy in Taiwanese. Hum Immunol. 71:712–716. 2010.
|
12
|
Zhang F, Liu H, Chen S, et al: Evidence
for an association of HLA-DRB1*15 and DRB1*09 with leprosy and the
impact of DRB1*09 on disease onset in a Chinese Han population. BMC
Med Genet. 10:1332009.
|
13
|
Ridley DS and Jopling WH: Classification
of leprosy according to immunity. A five-group system. Int J Lepr
Other Mycobact Dis. 34:255–273. 1966.PubMed/NCBI
|
14
|
Rangel-Villalobos H, Munoz-Valle JF,
Gonzalez-Martin A, Gorostiza A, Magana MT and Paez-Riberos LA:
Genetic admixture, relatedness, and structure patterns among
Mexican populations revealed by the Y-chromosome. Am J Phys
Antropol. 135:448–461. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Rubi-Castellanos R, Anaya-Palafox M,
Mena-Rojas E, Bautista-España D, Munoz-Valle JF and
Rangel-Villalobos H: Genetic data of 15 autosomal STRs (Identifiler
kit) of three Mexican Mestizo population samples from the States of
Jalisco (West), Puebla (Center), and Yucatan (Southeast). Forensic
Sci Int Genet. 3:e71–e76. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Miller SA, Dykes DD and Polesky HF: A
simple salting out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res. 16:12151988. View Article : Google Scholar : PubMed/NCBI
|
17
|
Yamamoto-Furusho JK, Uscanga LF,
Vargas-Alarcon G, Rodriguez-Perez JM, Zuniga J and Granados J:
Polymorphisms in the promoter region of tumor necrosis factor alpha
(TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with
ulcerative colitis. Immunol Lett. 95:31–35. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Geluk A and Ottenhoff TH: HLA and leprosy
in the pre and postgenomic eras. Hum Immunol. 67:439–445. 2006.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Blackwell JM and Searle S: Genetic
regulation of macrophage activation: understanding the function of
Nramp1 (=Ity/Lsh/Bcg). Immunol Lett. 65:73–80. 1999.PubMed/NCBI
|
20
|
Gorodezky C, Flores J, Arevalo N, Castro
LE, Silva A and Rodriguez O: Tuberculoid leprosy in Mexicans is
associated with HLA-DR3. Lepr Rev. 58:401–406. 1987.PubMed/NCBI
|
21
|
Gorodezky C, Alaez C, Munguia A, et al:
Molecular mechanisms of MHC linked susceptibility in leprosy:
towards the development of synthetic vaccines. Tuberculosis
(Edinb). 84:82–92. 2004. View Article : Google Scholar : PubMed/NCBI
|
22
|
Vargas-Alarcón G, Granados J,
Rodriguez-Pérez JM, et al: Distribution of HLA class II alleles and
haplotypes in Mexican Mestizo population: comparison with other
populations. Immunol Invest. 39:268–283. 2010.PubMed/NCBI
|
23
|
da Silva SA, Mazini PS, Reis PG, Sell AM,
Tsuneto LT, Peixoto PR and Visentainer JE: HLA-DR and HLA-DQ
alleles in patients from the south of Brazil: markers for leprosy
susceptibility and resistance. BMC Infect Dis. 9:1342009.PubMed/NCBI
|
24
|
Motta PM, Cech N, Fontan C, et al: Role of
HLA-DR and HLA-DQ alleles in multibacillary leprosy and
paucibacillary leprosy in the province of Chaco (Argentina). Enferm
Infecc Microbiol Clin. 25:627–631. 2007.(In Spanish).
|
25
|
Zerva L, Cizman B, Mehra NK, et al:
Arginine at positions 13 or 70–71 in pocket 4 of HLA-DRB1 alleles
is associated with susceptibility to tuberculoid leprosy. J Exp
Med. 183:829–836. 1996.
|
26
|
Soebono H, Giphart MJ, Schreuder GM,
Klatser PR and de Vries RR: Associations between HLA-DRB1 alleles
and leprosy in an Indonesian population. Int J Lepr Other Mycobact
Dis. 65:190–196. 1997.PubMed/NCBI
|
27
|
Hegazy AA, Abdel-Hamid IA, Ahmed el-SF,
Hammad SM and Hawas SA: Leprosy in a high-prevalence Egyptian
village: epidemiology and risk factors. Int J Dermatol. 41:681–686.
2002. View Article : Google Scholar : PubMed/NCBI
|
28
|
Rani R, Fernandez-Vina MA, Zaheer SA,
Beena KR and Stastny P: Study of HLA class II alleles by PCR
oligotyping in leprosy patients from north India. Tissue Antigens.
42:133–137. 1993. View Article : Google Scholar : PubMed/NCBI
|
29
|
Barquera R, Zuñiga J, Hernandez-Diaz R, et
al: HLA class I and class II haplotypes in admixed families from
several regions of Mexico. Mol Immunol. 45:1171–1178. 2008.
View Article : Google Scholar : PubMed/NCBI
|